Jane Street Group, LLC Ardelyx, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 1,259,096 shares of ARDX stock, worth $5.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,259,096

Previous 861,554 46.14%

Holding current value

$5.75 Million

Previous $6.38 Million 35.89%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.28 - $7.57 $2.1 Million - $3.01 Million	397,542 Added 46.14%	1,259,096 $8.68 Million
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.31 $2.12 Million - $3.34 Million	-359,207 Reduced 29.42%	861,554 $6.38 Million
Q1 2024 May 15, 2024	BUY	$6.05 - $9.74 $755,372 - $1.22 Million	124,855 Added 11.39%	1,220,761 $8.91 Million
Q4 2023 Feb 14, 2024	BUY	$3.29 - $6.64 $1.35 Million - $2.73 Million	411,689 Added 60.17%	1,095,906 $6.79 Million
Q3 2023 Nov 14, 2023	BUY	$3.3 - $4.83 $828,950 - $1.21 Million	251,197 Added 58.01%	684,217 $2.79 Million
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $309,824 - $474,808	95,921 Added 28.45%	433,020 $1.47 Million
Q1 2023 May 15, 2023	BUY	$2.68 - $4.79 $24,278 - $43,392	9,059 Added 2.76%	337,099 $1.61 Million
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $98,994 - $231,257	81,143 Added 32.87%	328,040 $934,000
Q3 2022 Nov 14, 2022	BUY	$0.59 - $1.44 $137,344 - $335,213	232,787 Added 1649.8%	246,897 $294,000
Q2 2022 Aug 16, 2022	SELL	$0.51 - $1.17 $15,468 - $35,486	-30,330 Reduced 68.25%	14,110 $9,000
Q1 2022 May 17, 2022	SELL	$0.65 - $1.18 $378,258 - $686,684	-581,936 Reduced 92.91%	44,440 $48,000
Q4 2021 Feb 15, 2022	BUY	$0.86 - $1.7 $317,766 - $628,143	369,496 Added 143.84%	626,376 $689,000
Q3 2021 Nov 16, 2021	BUY	$1.27 - $8.17 $244,850 - $1.58 Million	192,796 Added 300.85%	256,880 $339,000
Q2 2021 Aug 16, 2021	BUY	$6.55 - $8.98 $249,227 - $341,689	38,050 Added 146.16%	64,084 $486,000
Q1 2021 May 18, 2021	SELL	$6.1 - $7.69 $31,402 - $39,588	-5,148 Reduced 16.51%	26,034 $172,000
Q4 2020 Feb 17, 2021	BUY	$5.05 - $7.1 $34,643 - $48,706	6,860 Added 28.2%	31,182 $202,000
Q3 2020 Nov 17, 2020	SELL	$5.25 - $7.08 $54,012 - $72,839	-10,288 Reduced 29.73%	24,322 $128,000
Q2 2020 Aug 17, 2020	BUY	$5.37 - $8.11 $185,855 - $280,687	34,610 New	34,610 $240,000
Q4 2019 Feb 14, 2020	SELL	$4.23 - $8.29 $47,198 - $92,499	-11,158 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.15 - $6.28 $1,165 - $3,403	542 Added 5.11%	11,158 $52,000
Q2 2019 Aug 15, 2019	BUY	$2.49 - $3.73 $26,433 - $39,597	10,616 New	10,616 $29,000
Q1 2019 May 16, 2019	SELL	$1.88 - $3.35 $19,418 - $34,602	-10,329 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$1.66 - $4.16 $17,146 - $42,968	10,329 New	10,329 $18,000

Others Institutions Holding ARDX

# of Institutions

220

Shares Held

141M

Call Options Held

1.08M

Put Options Held

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $707M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Ardelyx, Inc. Transaction History